ABIONYX (EPA:ABNX) | WebDisclosure

Basculer en Français

9835	Companies
197436	Keywords
128527	Articles
105010	Press releases

Home
Companies
ABIONYX

PRESS RELEASE

published on 08/21/2025 at 23:15, 5 months 19 days ago

Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Communiqué de presse concernant le nombre total de droits de vote et d'actions d'ABIONYX Pharma. Détails sur le capital social et les droits de vote bruts et nets

Droits De Vote Capital Social Biopharma ABIONYX Pharma Inflammatoires
PRESS RELEASE

published on 08/21/2025 at 23:15, 5 months 19 days ago

Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
ABIONYX Pharma discloses monthly statement of total voting rights and shares on Euronext Paris. Company focused on innovative medicines in rare diseases

Euronext Paris Shares Total Voting Rights ABIONYX Pharma Innovative Medicines
BRIEF

published on 07/03/2025 at 19:40, 7 months 6 days ago

ABIONYX Pharma Half-Yearly Liquidity Contract Report

Liquidity Contract TP ICAP Financial Report Share Trading ABIONYX Pharma
BRIEF

published on 07/03/2025 at 19:40, 7 months 6 days ago

Rapport semestriel sur le contrat de liquidité d'ABIONYX Pharma

Contrat De Liquidité TP ICAP Rapport Financier Négociation D'actions ABIONYX Pharma
PRESS RELEASE

published on 07/03/2025 at 19:35, 7 months 6 days ago

Acquisition or disposal of the issuer's own shares / Information relating to the liquidity contract
ABIONYX Pharma releases half-yearly report showing assets in liquidity account with TP ICAP (Europe) SA, including shares and cash balance

Liquidity Contract Half-yearly Report Assets ABIONYX Pharma TP ICAP SA
PRESS RELEASE

published on 07/03/2025 at 19:35, 7 months 6 days ago

Acquisition ou cession des actions de l'émetteur / Information relative au contrat de liquidité
ABIONYX Pharma communique le bilan semestriel de son contrat de liquidité avec TP ICAP (Europe) SA, incluant actions et solde en espèces au 30 juin 2025

Contrat De Liquidité Bilan Semestriel Actions ABIONYX Pharma TP ICAP (Europe) SA
BRIEF

published on 06/27/2025 at 19:19, 7 months 12 days ago

ABIONYX Pharma Secures Approval for All General Meeting Resolutions

Shareholder Approval General Meeting Biotech Innovation ABIONYX Pharma ApoA-I Technology
BRIEF

published on 06/27/2025 at 19:19, 7 months 12 days ago

ABIONYX Pharma obtient l'approbation de toutes les résolutions de l'assemblée générale

Assemblée Générale Approbation Des Actionnaires Innovation Biotechnologique ABIONYX Pharma Technologie ApoA-I
PRESS RELEASE

published on 06/27/2025 at 19:14, 7 months 12 days ago

Inside Information / Other news releases
ABIONYX Pharma announces approval of all resolutions at Combined General Meeting. The biotech company is dedicated to innovative therapies

General Meeting Innovative Therapies Biotech Company Resolutions Approval ABIONYX Pharma
PRESS RELEASE

published on 06/27/2025 at 19:14, 7 months 12 days ago

Informations privilégiées / Autres communiqués
ABIONYX Pharma annonce l'approbation de l'ensemble des résolutions soumises au vote lors de son Assemblée Générale Mixte. Les résultats sont disponibles sur leur site web

Biotechnologie Resolutions Assemblée Générale Mixte Approbation ABIONYX Pharma

Accesswire

Published on 02/10/2026 at 13:30, 17 minutes ago

Revival Gold Intercepts 1.0 g/t Gold Over 30 Meters and Extends Mineralization at Mercur Project in Utah
Published on 02/10/2026 at 13:30, 17 minutes ago

Metallic Minerals Provides Keno Silver Project Update and Details 2026 Exploration Plans
Published on 02/10/2026 at 13:00, 47 minutes ago

Kalo Gold Advances 2026 Target Development at Vatu Aurum; Lidar and Orthophotography Completed; Airborne Geophysics Planned for February
Published on 02/10/2026 at 13:00, 47 minutes ago

NOA Lithium Announces Additional Warrant Exercises for $818,000
Published on 02/10/2026 at 13:00, 47 minutes ago

Neural Cloud Retains Commission Wolf to Accelerate U.S. Commercial Expansion

View all ACCESSWIRE

EQS Group

Published on 02/10/2026 at 13:35, 11 minutes ago

Bernd Spalt fulfils current contract – but does not seek extension
Published on 02/10/2026 at 13:15, 32 minutes ago

SCOPE’s Ultra-Luxury Residential Performance Underscores Strong Investor Confidence in Thailand’s Prime Market
Published on 02/10/2026 at 13:08, 38 minutes ago

Commerzbank exceeds profit target and launches further share buyback of up to €540m – dividend for 2025 to be €1.10 per share
Published on 02/10/2026 at 13:05, 42 minutes ago

Commerzbank exceeds profit target and launches further share buyback of up to €540m – dividend for 2025 to be €1.10 per share
Published on 02/10/2026 at 13:03, 43 minutes ago

EQS-Adhoc: Commerzbank Aktiengesellschaft: Commerzbank decides to implement a further share buyback

Les Echos

Published on 02/09/2026 at 18:00, 19 hours 47 minutes ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 janvier 2026
Published on 02/09/2026 at 17:45, 20 hours 2 minutes ago

Declaration of voting rights at the end of January 2026
Published on 02/09/2026 at 17:45, 20 hours 2 minutes ago

DAMARTEX / Droits de vote bruts et réels au 31 janvier 2026
Published on 02/09/2026 at 17:45, 20 hours 2 minutes ago

Déclaration des droits de vote à fin janvier 2026
Published on 02/09/2026 at 17:45, 20 hours 2 minutes ago

Déclaration des droits de vote à fin janvier 2026

View all LES ECHOS COMFI WIRE